DSC Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-57,700
Closed -$6.26M 22
2024
Q2
$6.26M Sell
57,700
-38
-0.1% -$4.48K 20.9% 2
2024
Q1
$7.62M Sell
57,738
-12,295
-18% -$1.54M 12.17% 4
2023
Q4
$8.52M Buy
70,033
+5,291
+8% +$590K 14.08% 4
2023
Q3
$7.27M Buy
64,742
+2,208
+4% +$280K 9.33% 4
2023
Q2
$9.1M Buy
62,534
+5
+0% +$679 13.65% 3
2023
Q1
$8.08M Sell
62,529
-1
-0% -$126 7.05% 6
2022
Q4
$7.97M Buy
62,530
+30
+0% +$3.48K 18.32% 4
2022
Q3
$6.53M Buy
62,500
+2,470
+4% +$271K 6.73% 4
2022
Q2
$6.31M Buy
60,030
+12,030
+25% +$1.43M 6.3% 4
2022
Q1
$6.14M Buy
48,000
+6,229
+15% +$751K 2.11% 7
2021
Q4
$5.15M Buy
+41,771
New +$5.47M 3.98% 7
2020
Q1
Sell
-80,773
Closed -$11.7M 83
2019
Q4
$11.7M Sell
80,773
-6,606
-8% -$912K 5.62% 5
2019
Q3
$11.6M Buy
87,379
+90
+0.1% +$11.6K 2.3% 8
2019
Q2
$9.98M Buy
87,289
+5,091
+6% +$596K 1.75% 13
2019
Q1
$10.2M Buy
82,198
+22,686
+38% +$2.58M 1.87% 9
2018
Q4
$5.99M Buy
59,512
+14,819
+33% +$1.67M 0.73% 16
2018
Q3
$5.7M Buy
+44,693
New +$5.31M 0.77% 19

Other funds holding ZBH

DSC Advisors's ZBH Position: Q3 2024 in Review

DSC Advisors sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 57,700 shares — an estimated $6.26M sold.

DSC Advisors first reported a position in ZBH in Q3 2018 and held it in 17 quarters. The position peaked at $11.7M in Q4 2019. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

  • DSC Advisors reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
  • DSC Advisors sold 57,700 Zimmer Biomet shares in Q3 2024, an estimated $6.26M.
  • DSC Advisors first reported a position in Zimmer Biomet in Q3 2018 and held it in 17 quarters.
  • DSC Advisors's Zimmer Biomet position peaked at $11.7M in Q4 2019.
  • 981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on DSC Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.